Link Pharma Chem Ltd

As of 14-Nov, Link Pharma Chem Ltd's stock price is Rs 34.95, up 4.14% today but down 14.76% year-to-date. Despite a short-term gain, the stock's long-term performance is weak compared to the broader market, indicating potential challenges ahead.

Link Pharma Chem has experienced a significant decline in net sales and profitability, with losses reported in the most recent fiscal year. Net sales dropped from 53.56 Cr in March 2022 to 25.43 Cr in March 2025, and the company reported a profit after tax loss of -1.03 Cr in March 2025.

Link Pharma Chem will announce its results on 13 November 2025.

As of 07-Nov, Link Pharma Chem Ltd's stock price is Rs 32.61, down 6.72%, significantly underperforming its sector and the broader market. The stock has shown high volatility and decreased investor participation, with notable declines over the past week, month, and year.

As of 07-Oct, Link Pharma Chem Ltd is priced at 35.00, having increased by 0.75%. The stock has shown erratic trading patterns and is currently underperforming compared to the Sensex, with a 4.53% decline over the past week and a year-to-date drop of 14.63%.

As of 01-Oct, Link Pharma Chem Ltd is currently priced at 37.00, showing a short-term gain of 0.93% but a year-to-date decline of 9.76%. Despite recent positive trends, the stock's long-term performance is under pressure compared to the broader market.

As of 29-Sep, Link Pharma Chem Ltd's stock price is Rs 35.00, down 6.57%, with significant underperformance compared to its sector and a bearish trend indicated by trading below all major moving averages. The stock has seen a drastic drop in delivery volume and has underperformed the Sensex year-to-date, despite a recent month of relative outperformance.

As of 26-Sep, Link Pharma Chem Ltd's stock price is at 37.46, unchanged. Despite a recent 6.81% weekly rise, the stock has significant long-term concerns, including a -183.49% CAGR in operating profits over five years and a negative return on equity of 5.21%.

As of 19-Sep, Link Pharma Chem Ltd is priced at 35.05, down -1.99%, and has underperformed with a -7.74% loss over the last two days. The stock is trading below key moving averages, indicating a bearish trend, and has seen a significant drop in investor participation.

As of 11-Sep, Link Pharma Chem Ltd's stock price is declining at 35.00, down 1.96%, and has underperformed its sector. The company faces significant financial challenges, including negative growth in operating profits and a bearish outlook due to weak fundamentals.

As of 09-Sep, Link Pharma Chem Ltd's stock price is at 34.27, down 1.38%, and has underperformed its sector. The company shows weak fundamentals with declining sales, negative operating profits, and a poor ability to service debt, contributing to its overall poor stock performance.

As of 08-Sep, Link Pharma Chem Ltd's stock price is at 34.75, down 2.11%, and has significantly underperformed its sector. The company faces weak fundamentals, with a year-to-date decline of 15.24% and a substantial drop in investor participation, indicating ongoing financial challenges.

As of 05-Sep, Link Pharma Chem Ltd is priced at 35.50 with no change in price. Despite recent short-term gains, the stock has underperformed significantly over the year, down 20.39% compared to a 1.81% decline in the Sensex, indicating potential underlying issues affecting investor sentiment.

As of 04-September, Link Pharma Chem Ltd's stock price is at 35.50, up 1.43% today, with a short-term gain of 8.70% over the past week. However, it has declined 13.41% year-to-date, indicating significant long-term challenges despite recent positive performance.

As of 03-Sep, Link Pharma Chem Ltd's stock price is Rs 35.00, up 2.94% today, but it has a negative trend with a 4.27% decline over the past month and a 14.63% drop year-to-date. Despite today's outperformance, long-term fundamentals are weak, indicating significant challenges ahead.

As of 02-Sep, Link Pharma Chem Ltd's stock price is Rs 34.00, down 5.29%, and has underperformed its sector. The stock shows weak fundamentals and negative returns, indicating significant challenges ahead.

As of 29-Aug, Link Pharma Chem Ltd is priced at 33.15, having increased by 1.5% after a decline. Despite this uptick, the stock underperforms the Sensex and shows significant long-term financial weaknesses, indicating it may be a risky investment.

As of 28-Aug, Link Pharma Chem Ltd's stock price is Rs 32.66, down 5.77%, with a total loss of 9% over the last two days and a year-to-date decline of 20.34%. Weak fundamentals, including poor profit growth and declining sales, alongside significant underperformance compared to the market, indicate a challenging outlook for the stock.